Holen Sie sich die Stockscreener-App
46.80
1.21%
0.56
Handel nachbörslich:
46.80
Schlusskurs vom Vortag:
$46.24
Offen:
$46.27
24-Stunden-Volumen:
1.07M
Relative Volume:
0.82
Marktkapitalisierung:
$10.03B
Einnahmen:
$1.98B
Nettoeinkommen (Verlust:
$83.59M
KGV:
125.13
EPS:
0.374
Netto-Cashflow:
$502.31M
1W Leistung:
+6.61%
1M Leistung:
+0.21%
6M Leistung:
+15.93%
1J Leistung:
+4.50%
1-Tages-Spanne:
$46.23
$46.88
1-Wochen-Bereich:
$43.74
$46.88
52-Wochen-Spanne:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie QGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
46.80 | 10.03B | 1.98B | 83.59M | 502.31M | 0.374 |
|
TMO
Thermo Fisher Scientific Inc
|
543.32 | 198.23B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
214.99 | 150.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
631.19 | 50.71B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.64 | 39.32B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
206.63 | 34.74B | 15.70B | 1.24B | 2.01B | 6.9036 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-10-14 | Eingeleitet | Redburn | Buy |
| 2021-07-14 | Herabstufung | Kepler | Buy → Hold |
| 2021-06-03 | Eingeleitet | Goldman | Neutral |
| 2020-10-06 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-28 | Hochstufung | Kepler | Hold → Buy |
| 2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
| 2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
| 2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
111 Capital Purchases Shares of 47,321 Qiagen N.V. $QGEN - MarketBeat
QIAGEN (NYSE:QGEN) Stock Rating Lowered by Wall Street Zen - MarketBeat
What Qiagen N.V.'s (NYSE:QGEN) P/S Is Not Telling You - 富途牛牛
Will Qiagen N.V. stock attract more institutional investorsJuly 2025 Momentum & Technical Pattern Based Signals - newser.com
Can Qiagen N.V. (QIA) stock deliver double digit returns2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
How Qiagen N.V. stock reacts to oil pricesPortfolio Risk Summary & Verified Short-Term Trading Plans - newser.com
QIAGEN Receives Several Conditional, Non-binding Indications of Interest, Enters Into Discussions to Explore Potential Strate... - ADVFN
How geopolitical risks impact Qiagen N.V. Common Shares stockMarket Movement Recap & Safe Entry Momentum Tips - newser.com
Does Qiagen N.V. Common Shares stock trade below intrinsic valueTrade Risk Summary & Detailed Earnings Play Alerts - newser.com
Will Qiagen N.V. price bounce be sustainableWeekly Profit Analysis & High Return Stock Watch Alerts - newser.com
Why Qiagen N.V. (QIA) stock appears on watchlistsWeekly Investment Recap & Entry Point Confirmation Signals - newser.com
Can Qiagen N.V. (QIA) stock deliver consistent EPS growthMarket Activity Report & AI Driven Stock Reports - newser.com
What dividend safety score for Qiagen N.V. stock2025 Key Lessons & Daily Technical Forecast Reports - newser.com
Statistical indicators supporting Qiagen N.V.’s strength2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
How Qiagen N.V. Common Shares stock trades after rate cutsJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com
How cyclical is Qiagen N.V. (QIA) stock compared to rivalsBull Run & Real-Time Volume Spike Alerts - newser.com
Qiagen (QGEN) Analyst Maintains Rating But Lowers Price Target | QGEN Stock News - GuruFocus
Barclays Maintains Qiagen NV(QGEN.US) With Buy Rating, Cuts Target Price to $53 - 富途牛牛
QIAGEN N.V. Pre-announces 2025 Half-Year Financial Report - MSN
Sysmex : Partners with QIAGEN for Exclusive Distribution and Supply of Clinical Diagnostic Products in Infectious Diseases and Oncology in Japan - MarketScreener
Qiagen N : Halfjaarlijkse financiële verslaggeving - MarketScreener
What drives Qiagen NV QIA stock priceMarket Entry Points & Low Risk Trading Portfolio - earlytimes.in
What analysts say about Qiagen NV stockInsider Trading Activity & Affordable Investment Portfolio - earlytimes.in
Is Qiagen NV a good long term investmentMomentum Trading Signals & Budget Friendly Trading Ideas - earlytimes.in
What drives Qiagen NV stock priceInsider Selling Patterns & Low Risk Investment Growth - Early Times
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.01%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):